scholarly journals Brain Metastasis of Alveolar Soft Part Sarcoma treated Successfully with Hypothermia: A Case Report

1997 ◽  
Vol 6 (6) ◽  
pp. 408-412
Author(s):  
Satoshi Sawauchi ◽  
Shigehiko Kabe ◽  
Kouichi Takahashi ◽  
Masahiko Akiyama ◽  
Ikuo Shukuya ◽  
...  
2021 ◽  
Vol 12 ◽  
pp. 111
Author(s):  
Mark A. Damante ◽  
Kristin M. Huntoon ◽  
Joshua D. Palmer ◽  
David A. Liebner ◽  
James Bradley Elder

Background: Alveolar soft part sarcoma (ASPS) is a rare soft-tissue sarcoma with a propensity for early hematogenous dissemination to the lungs and frequent brain metastasis. The development of lung metastasis almost invariably precedes intracranial involvement. There are no previously reported cases in which a patient was synchronously diagnosed with ASPS and multiple brain metastasis without lung involvement. Case Description: A 29-year-old gentleman was found to have three intracranial lesions following the onset of generalized seizures. Staging studies identified a soft-tissue mass in the left thigh and an adjacent femoral lesion. Biopsy of the soft-tissue mass was consistent with ASPS. The patient then underwent neoadjuvant stereotactic radiotherapy to all three brain lesions, followed by en bloc resection of the dominant lesion. The patient was then started on a programmed death-ligand 1 (PD-L1) inhibitor. Subsequent surgical resection of the primary lesion and femur metastasis demonstrates a histopathologic complete response of the bony metastasis and partial response of the primary lesion. At present, the patient has received 14 cycles of atezolizumab without recurrence of the primary or bony lesions and the irradiated intracranial disease has remained stable without recurrence of the resected dominant lesion. Conclusion: While intracranial involvement is relatively common in ASPS, a case with multiple, synchronously diagnosed brain metastasis without concurrent lung metastasis has not been described. The presented case discusses the safety and efficacy of aggressive management of intracranial disease in the setting of atezolizumab. Prospective evaluation of the efficacy of checkpoint inhibitors and the prognostic value of PD-L1 expression in ASPS with brain metastasis are necessary.


2022 ◽  
Vol 10 (1) ◽  
pp. 296-303
Author(s):  
Jun-Yu Chen ◽  
Bo Cen ◽  
Fei Hu ◽  
Yong Qiu ◽  
Guo-Min Xiao ◽  
...  

1983 ◽  
Vol 65 (6) ◽  
pp. 841-842 ◽  
Author(s):  
A E Brodsky ◽  
M D Dennis ◽  
W R Sassard

2020 ◽  
pp. 014556132095513
Author(s):  
Saud Alromaih ◽  
Saleh Alqaryan ◽  
Saleh Alabood ◽  
Somaya Alabaishi ◽  
Abdulrazag Ajlan ◽  
...  

Sinonasal alveolar soft-part sarcoma (ASPS) is a rare malignant disease that comprises 0.4% to 1.2% of all soft-tissue sarcomas. Alveolar soft-part sarcoma is usually difficult to diagnose because it has many clinical and pathological mimickers. In this case study, ASPS occurred in the olfactory cleft, representing the second case in this location in the literature. This article presents the clinical presentation, radiologic, and histopathological case, and reviews the literature regarding the differentials.


1995 ◽  
Vol 113 (2) ◽  
pp. P191-P191
Author(s):  
M. Gregory DeSautel ◽  
Regina-Edwards Gandour ◽  
Philip Vogt ◽  
Paul J. Donald

2009 ◽  
Vol 38 (8) ◽  
pp. 825-829 ◽  
Author(s):  
Fei-Peng Zhu ◽  
Guang-Ming Lu ◽  
Long-Jiang Zhang ◽  
Jian-Dong Wang ◽  
Xiao-Jing An ◽  
...  

2009 ◽  
Vol PAP ◽  
Author(s):  
Denisa Kacerovska ◽  
Michal Michal ◽  
Jana Nemcova ◽  
Tomas Vanecek ◽  
Boris Kreuzberg ◽  
...  

Author(s):  
Andrew P. Katz ◽  
Sonja Chen ◽  
Bradley D. DeNardo ◽  
Shamlal Mangray ◽  
Jan C. Groblewski

Sign in / Sign up

Export Citation Format

Share Document